英科医疗(300677.SZ)：2025年三季报净利润为9.24亿元

Core Insights - In Q3 2025, the company reported total revenue of 7.425 billion yuan and a net profit attributable to shareholders of 924 million yuan, with net cash inflow from operating activities amounting to 1.107 billion yuan [1] Financial Performance - The company's latest debt-to-asset ratio stands at 53.79%, which is an increase of 0.13 percentage points from the previous quarter and an increase of 3.98 percentage points year-on-year [3] - The latest gross profit margin is 23.70%, reflecting a decrease of 0.53 percentage points from the previous quarter [3] - The return on equity (ROE) is reported at 5.09% [3] - The diluted earnings per share (EPS) is 1.45 yuan [3] - The total asset turnover ratio is 0.20 times, a decrease of 0.03 times compared to the same period last year, representing a year-on-year decline of 14.66% [3] - The inventory turnover ratio is 4.44 times, down 0.12 times year-on-year, which is a decline of 2.63% [3] Shareholder Structure - The number of shareholders is 47,300, with the top ten shareholders holding a total of 288 million shares, accounting for 43.98% of the total share capital [4] - The largest shareholder is Liu Fangyi, holding 35.3 million shares [4] - Other significant shareholders include various investment funds and banks, with holdings ranging from 0.46 million to 1.95 million shares [4]